We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
-12.98%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$242M
AUM Growth
-$78.3M
Cap. Flow
-$27.2M
Cap. Flow %
-11.28%
Top 10 Hldgs %
56%
Holding
50
New
12
Increased
8
Reduced
19
Closed
9

Top Buys

Rank Stock Value
1
VPG icon
Vishay Precision Group
VPG
+$6.15M
2
DOMO icon
Domo
DOMO
+$6.02M
3
AKBA icon
Akebia Therapeutics
AKBA
+$5.97M
4
HRTX icon
Heron Therapeutics
HRTX
+$5.39M
5
ZVRA icon
Zevra Therapeutics
ZVRA
+$5.16M

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$16.6M
2
DCTH icon
Delcath Systems
DCTH
+$16M
3
TARS icon
Tarsus Pharmaceuticals
TARS
+$12.4M
4
XERS icon
Xeris Biopharma Holdings
XERS
+$8.73M
5
GLW icon
Corning
GLW
+$3.7M

Sector Composition

Rank Sector Weight
1 Healthcare 50.86%
2 Technology 21.98%
3 Industrials 6.95%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRCE
26
Grace Therapeutics
GRCE
$34.7M
$3.02M 1.25%
1,322,379
+801,296
+154% +$2.52M
BDSX icon
27
Biodesix
BDSX
$248M
$2.67M 1.11%
213,630
-95,361
-31% -$1.83M
PYPD icon
28
PolyPid
PYPD
$92.8M
$2.55M 1.06%
940,381
+112,514
+14% +$335K
FKWL icon
29
Franklin Wireless
FKWL
$27M
$2.2M 0.91%
385,350
-4,650
-1% -$26.4K
FENC icon
30
Fennec Pharmaceuticals
FENC
$402M
$2.2M 0.91%
+361,005
New +$2.32M
TELA icon
31
TELA Bio
TELA
$38.9M
$1.73M 0.72%
1,416,323
-1,246,462
-47% -$3.06M
AMPG icon
32
AmpliTech
AMPG
$147M
$1.4M 0.58%
+905,453
New +$1.84M
APPS icon
33
Digital Turbine
APPS
$1.74B
$1.17M 0.48%
+430,849
New +$1.4M
KALA icon
34
KALA BIO
KALA
$14.5M
$1.13M 0.47%
3,927
+1,501
+62% +$568K
APRE icon
35
Aprea Therapeutics
APRE
$8.05M
$1.1M 0.46%
539,300
– –
PHGE icon
36
BiomX
PHGE
$1.85M
$871K 0.36%
82,471
+36,924
+81% +$515K
SMTK
37
SmartKem
SMTK
$3.99M
$855K 0.35%
291,681
+135,194
+86% +$395K
KPRX icon
38
Kiora Pharmaceuticals
KPRX
$11.7M
$763K 0.32%
253,555
-2,000
-0.8% -$6.95K
BFRI icon
39
Biofrontera
BFRI
$16.3M
$586K 0.24%
732,155
-78,942
-10% -$81.2K
INAB icon
40
IN8bio
INAB
$9.64M
$241K 0.1%
48,333
-158,063
-77% -$1.26M
NRXS icon
41
Neuraxis
NRXS
$88.5M
$42.7K 0.02%
+19,869
New +$47.9K
GLW icon
42
Corning
GLW
$143B
– –
-75,000
Closed -$3.7M
INO icon
43
Inovio Pharmaceuticals
INO
$69M
– –
-654,115
Closed -$1.2M
MCHX icon
44
Marchex
MCHX
$79.7M
– –
-198,100
Closed -$347K
MRVL icon
45
CALL
Marvell Technology
MRVL
$196B
– –
-200,000
Closed -$22.1M
MRVL icon
46
Marvell Technology
MRVL
$196B
– –
-150,000
Closed -$16.6M
CNSY
47
Cerenome, Inc. Common Stock
CNSY
$26.4M
– –
-22,436
Closed -$645K
TARS icon
48
Tarsus Pharmaceuticals
TARS
$2.84B
– –
-224,713
Closed -$12.4M
XAIR icon
49
Beyond Air
XAIR
$3.86M
– –
-2,479
Closed -$355K
XERS icon
50
Xeris Biopharma Holdings
XERS
$1.37B
– –
-2,574,846
Closed -$8.73M
1
2

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, AIGH Capital Management held 50 positions worth $242M, down 24% from $320M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

AIGH Capital Management withdrew a net $27.2M in Q1 2025, closing 9 positions and reducing 19 holdings. Its most notable exit was Marvell Technology, an estimated $16.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Vishay Precision Group worth $6.35M.

  • AIGH Capital Management's largest Q1 2025 buy was Vishay Precision Group: 263,565 shares worth $6.35M.
  • AIGH Capital Management added most to Zevra Therapeutics in Q1 2025, an estimated $5.16M increase.
  • AIGH Capital Management's biggest Q1 2025 reduction was Delcath Systems, cutting an estimated $16M.
  • AIGH Capital Management fully exited Marvell Technology in Q1 2025, selling an estimated $16.6M.
  • AIGH Capital Management's ten largest holdings make up 56% of its $242M portfolio in Q1 2025.
  • AIGH Capital Management opened 12 new positions and closed 9 in Q1 2025.
  • AIGH Capital Management's portfolio value fell 24% quarter-over-quarter to $242M.

Based on AIGH Capital Management's 13F filing for Q1 2025, filed 6 May 2025.